Search results
CNN’s Presidential Debate: A Rematch With New Rules That Will Make History
The Wrap via Yahoo News· 2 weeks agoBypassing the Commission on Presidential Debates allows the network to limit crosstalk and heckling...
We Need Regulatory Clarity to Keep Crypto Exchanges Onshore and DeFi Permissionless
CoinDesk via Yahoo News· 1 year agoThe lack of clear crypto regulation risks sending companies overseas. Congress must bring regulatory...
What Now for Crypto Banking?
CoinDesk via Yahoo News· 1 year agoRegulators are leery of traditional banks offering services to crypto companies, and wary of specialist crypto banks, like Custodia, with new business...
DeFi Must Be Defended
CoinDesk via Yahoo News· 2 years agoAs the crypto policy world debates the future of stablecoins and the legal culpability of decentralized autonomous organization (DAO) governance voters,...
US Senate Bill Will Give CFTC Crypto Market Oversight – but Doesn't Say How Much
CoinDesk via Yahoo News· 2 years agoThe latest U.S. legislative effort to steer most crypto oversight into the hands of the Commodity...
Crypto Is Capitol Hill’s Last ‘Bipartisan Issue,’ Coinbase Exec Says
CoinDesk via Yahoo News· 2 years agoFaryar Shirzad, chief policy officer at Coinbase, joined CoinDesk TV’s “First Mover” to discuss the...
Unveiling the Uniswap Foundation's Bridge Report: Winners and Losers
CoinDesk via Yahoo News· 1 year agoWormhole and Axelar take top honors after a months-long assessment process aimed at addressing...
Web3 Done Right: Token-Gated Access May Be the Ticket for Hollywood | PRO Insight
The Wrap via Yahoo News· 1 year agoIn a recent column, I wrote about an example of what’s wrong in the NFT world from the creative...
Bye-bye Brokers: EU Tries Stock Trading, the Web3 Way
CoinDesk via Yahoo News· 2 years agoA new European trial of blockchain-based securities trading is a “very good thing” for crypto fans,...
Mark Cuban Cost Plus Drugs Company takes another step 'to disrupt the current pharmacy supply chain'
Yahoo Finance· 2 years agoThe Mark Cuban Cost Plus Drug Company is teaming up with EmsanaRx, a pharmacy benefit manager, to...
